Loading...
Loading...
India's valsartan imports from GERMANY total $57.2K across 71 shipments from 13 foreign suppliers. PRIVAPOSERVICES GMBH leads with $40.0K in import value; the top 5 suppliers together control 90.8% of this origin. Leading Indian buyers include MACLEODS PHARMACEUTICALS LTD. This corridor reflects India's pharmaceutical import demand for valsartan — a diversified sourcing base with multiple active suppliers from GERMANY.

PRIVAPOSERVICES GMBH is the leading Valsartan supplier from GERMANY to India, with import value of $40.0K across 31 shipments. The top 5 suppliers — PRIVAPOSERVICES GMBH, E-PHARM LIMITED, ESPEE PHARMA (UK) LTD., AMSTERDAM PHARMA APTEKA RX INC, ESPEE PHARMA (UK) LTD — collectively account for 90.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PRIVAPOSERVICES GMBH | $40.0K | 31 | 69.9% |
| 2 | E-PHARM LIMITED | $4.4K | 6 | 7.7% |
| 3 | ESPEE PHARMA (UK) LTD. | $3.6K | 3 | 6.2% |
| 4 | AMSTERDAM PHARMA APTEKA RX INC | $2.6K | 3 | 4.5% |
| 5 | ESPEE PHARMA (UK) LTD | $1.4K | 3 | 2.4% |
| 6 | Privaposervices GmbH | $1.3K | 2 | 2.3% |
| 7 | MERCKLE GMBH | $1.1K | 11 | 1.9% |
| 8 | NEWLIFE BIOPHARMA LIMITED | $1.0K | 4 | 1.8% |
| 9 | SIA GP NORD | $797 | 2 | 1.4% |
| 10 | ALFRED E. TIEFENBACHER(GMBH & CO.KG) | $727 | 2 | 1.3% |
| 11 | ILAPO | $265 | 1 | 0.5% |
| 12 | ALFRED E TIEFENBACHER GMBH CO KG | $17 | 2 | 0.0% |
| 13 | Myonex GmbH, | $13 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD | $14.5K | 6 | 25.4% |
| 2 | DR.REDDY'S LABORATORIES LTD | $12.0K | 6 | 21.0% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $9.3K | 11 | 16.3% |
| 4 | IPCA LABORATORIES LIMITED | $5.3K | 7 | 9.3% |
| 5 | TORRENT PHARMACEUTICALS LTD | $3.6K | 3 | 6.2% |
| 6 | ALKEM LABORATORIES LIMITED | $2.6K | 3 | 4.5% |
| 7 | INTAS PHARMACEUTICALS LIMITED | $1.4K | 3 | 2.4% |
| 8 | HETERO LABS LIMITED | $1.3K | 2 | 2.3% |
| 9 | DR.REDDY'S LABORATORIES LIMITED | $1.3K | 2 | 2.3% |
| 10 | ZYDUS LIFESCIENCES LIMITED | $1.1K | 3 | 1.9% |
| 11 | CORONA REMEDIES LIMITED | $1.0K | 2 | 1.8% |
| 12 | DR REDDY S LABORATORIES LIMITED | $868 | 2 | 1.5% |
| 13 | INDOCO REMEDIES LIMITED | $813 | 2 | 1.4% |
| 14 | AET LABORATORIES PRIVATE LIMITED | $744 | 4 | 1.3% |
| 15 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $699 | 6 | 1.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Valsartan suppliers from GERMANY to India include PRIVAPOSERVICES GMBH, E-PHARM LIMITED, ESPEE PHARMA (UK) LTD.. The leading supplier is PRIVAPOSERVICES GMBH with import value of $40.0K USD across 31 shipments. India imported Valsartan worth $57.2K USD from GERMANY in total across 71 shipments.
India imported Valsartan worth $57.2K USD from GERMANY across 71 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Valsartan sourced from GERMANY include MACLEODS PHARMACEUTICALS LTD, DR.REDDY'S LABORATORIES LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED. The largest buyer is MACLEODS PHARMACEUTICALS LTD with $14.5K in imports across 6 shipments.
The total value of Valsartan imports from GERMANY to India is $57.2K USD, across 71 shipments and 13 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
71 Verified Shipments
13 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists